NDC 50090-0481-01 - Naproxen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-0481
- Requested NDC
- 50090-0481-01
- Package NDCs from labels
- 50090-0481-0, 50090-0481-7, 50090-0481-4, 50090-0481-5, 50090-0481-1, 50090-0481-9, 50090-0481-2, 50090-0481-6, 50090-0481-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-01-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Naproxen - A-S Medication Solutions | A-S Medication Solutions | 2026-01-29 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-0481-0 | Naproxen | 15 in 1 BOTTLE | TABLET | 15 | 31 | |
| 50090-0481-1 | Naproxen | 20 in 1 BOTTLE | TABLET | 20 | 31 | |
| 50090-0481-2 | Naproxen | 30 in 1 BOTTLE | TABLET | 30 | 31 | |
| 50090-0481-4 | Naproxen | 14 in 1 BOTTLE | TABLET | 14 | 31 | |
| 50090-0481-5 | Naproxen | 40 in 1 BOTTLE | TABLET | 40 | 31 | |
| 50090-0481-6 | Naproxen | 100 in 1 BOTTLE | TABLET | 100 | 31 | |
| 50090-0481-7 | Naproxen | 60 in 1 BOTTLE | TABLET | 60 | 31 | |
| 50090-0481-9 | Naproxen | 6 in 1 BOTTLE | TABLET | 6 | 31 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-0481 | NAPROXEN TABLET [A-S MEDICATION SOLUTIONS] | 29 | Current NDC, Legacy NDC, 8 package rows | 20240905_000155a8-709c-44e5-a75f-cd890f3a7caf.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-0481-0 | EA - Each | 50090-0481 | b73d0457-aa5d-44d1-9ffe-8e84bc4b53d5 | 1 | 2018-09-05 |
| 50090-0481-1 | EA - Each | 50090-0481 | 8d86527d-2599-4a30-82a6-c2dbd1b98722 | 1 | 2018-09-05 |
| 50090-0481-2 | EA - Each | 50090-0481 | d92301e9-5ae9-43b2-b86b-e58dad9eaea9 | 1 | 2018-09-05 |
| 50090-0481-4 | EA - Each | 50090-0481 | 1442acf3-7793-4a96-8ebf-f200f2e60bce | 1 | 2018-09-05 |
| 50090-0481-5 | EA - Each | 50090-0481 | bac00d6f-6aa6-473b-a517-2d181646cda1 | 1 | 2018-09-05 |
| 50090-0481-6 | EA - Each | 50090-0481 | 3c8620e3-6f7e-46f4-a0de-5ad10fba1c21 | 1 | 2018-09-05 |
| 50090-0481-7 | EA - Each | 50090-0481 | 33b2100d-a17f-4f6d-bad0-120a73bada72 | 1 | 2018-09-05 |
| 50090-0481-9 | EA - Each | 50090-0481 | 08fbf0d0-348d-48a8-b1a1-760f87e60643 | 1 | 2018-09-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MINIDROPS | LUBRICANT EYE DROPS | Optics Laboratory, Inc | c13c5f91-50df-471c-a7c9-1747a2ac1250 | 2026-02-03 | Warnings | FZ989GH94E |
| Aquavit 1 | AQUAVIT 1 | Uriel Pharmacy Inc. | 2354fcfc-05a2-444a-ace4-b3df61413157 | 2026-02-02 | Warnings | 1K09F3G675 |
| Naproxen | NAPROXEN | A-S Medication Solutions | 4e97e645-552d-424b-990a-f94349a86f17 | 2026-01-30 | Boxed warning, Warnings, Adverse reactions | ANDA078250 198014 57Y76R9ATQ |
| Good Sense Naproxen Sodium | NAPROXEN SODIUM | L. Perrigo Company | 6bc74cda-458c-480e-a33c-d2ba68d5e6bd | 2026-01-29 | Warnings | 9TN87S3A3C |
| Care One Naproxen Sodium | NAPROXEN SODIUM | American Sales Company | bc5ddcf2-640c-4683-a60f-ca1c8b418873 | 2026-01-29 | Warnings | 9TN87S3A3C |
| Calamine | CALAMINE | AMERISOURCE BERGEN | 90d9d908-57ea-4062-ade0-8a4888939c91 | 2026-01-29 | Warnings, Adverse reactions | 1K09F3G675 |
| Naproxen | NAPROXEN | A-S Medication Solutions | 000155a8-709c-44e5-a75f-cd890f3a7caf | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | ANDA078250 50090-0481-6 50090-0481-2 50090-0481-4 50090-0481-0 50090-0481-9 50090-0481-5 50090-0481-7 50090-0481-1 50090-0481 50090048101 198014 8c45ef1f-f708-485b-bc20-60aa87ce6289 000155a8-709c-44e5-a75f-cd890f3a7caf 57Y76R9ATQ |
| Naproxen | NAPROXEN | A-S Medication Solutions | d06db628-f6f0-48e2-b538-69c0837c49e3 | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | ANDA078250 198014 198012 57Y76R9ATQ |
| Naproxen | NAPROXEN | A-S Medication Solutions | 9d28422f-6f25-4f14-9272-e0907c971f33 | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | ANDA078250 849431 198014 198012 57Y76R9ATQ |
| Naproxen Sodium | NAPROXEN SODIUM | Bryant Ranch Prepack | 1c2325f7-1d65-429d-a64d-6ab075df1c20 | 2026-01-28 | Boxed warning, Warnings, Adverse reactions | 849398 9TN87S3A3C |
| Flanax Menstrual Pain Reliever | NAPROXEN SODIUM | Belmora LLC | 2b4135b3-389c-46e2-ae86-7674c2ab9a32 | 2026-01-27 | Warnings | 9TN87S3A3C |
| BACK AND MUSCLE PAIN | NAPROXEN | WALGREENS | 81417810-8a34-c859-e053-2a91aa0a6507 | 2026-01-26 | Warnings | 9TN87S3A3C |
| Leader All Day Pain Relief | NAPROXEN SODIUM | Cardinal Health 110, LLC. dba Leader | dbf007f5-c792-43a7-8cc1-bfa617f3a7fa | 2026-01-26 | Warnings | 9TN87S3A3C |
| Naproxen | NAPROXEN | Preferred Pharmaceuticals Inc. | 87acd650-ea8a-4396-be72-5568c4b1755c | 2026-01-23 | Boxed warning, Warnings, Adverse reactions | ANDA078250 198014 57Y76R9ATQ |
| naproxen sodium | NAPROXEN SODIUM | Meijer Distribution Inc | f4e57560-ae89-4fc3-a66b-ebf3dc3f2448 | 2026-01-22 | Warnings | 9TN87S3A3C |
| Naproxen and esomeprazole magnesium | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM | Preferred Pharmaceuticals Inc. | b295a90e-320f-4414-b80a-d11f06c00c96 | 2026-01-20 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Naproxen Sodium | NAPROXEN SODIUM | HYVEE INC | 45a00020-173b-a4a1-e063-6294a90ae399 | 2026-01-13 | Warnings | 9TN87S3A3C |
| First Chakra (Root) 7301 | FIRST CHAKRA (ROOT) | Professional Complementary Health Formulas | 61eb1bbe-6675-4369-b852-18975e6b08c7 | 2026-01-08 | Warnings | 1K09F3G675 |
| Naprelan | NAPROXEN SODIUM | Upsher-Smith Laboratories, LLC | b8a51c9a-488e-4377-a041-436f6a2f8893 | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | 9TN87S3A3C |
| Third Chakra (Solar Plexus) 7303 | THIRD CHAKRA (SOLAR PLEXUS) | Professional Complementary Health Formulas | eea89c37-ab87-4cc7-8dfc-e7f42a580dd9 | 2026-01-08 | Warnings | 1K09F3G675 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.